Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
DryShips (DRYS) Lower Following 6M Share Offering
-
Cantor Fitzgerald Upgrades Euroseas (ESEA) to Buy; $18 PT
-
Cantor Fitzgerald Initiates Coverage on CDC Corp. (CHINA) with a Buy
-
Cantor Fitzgerald Downgrades Veraz Networks (VRAZ) to Hold
-
Cantor Fitzgerald Reiterates Buy on Senomyx (SNMX); $26 PT
-
Cantor Fitzgerald upgrades RADVISION (RVSN) to Buy
-
Cantor Fitzgerald Upgrades Genomic Health (GHDX) to Buy
-
Cantor Fitzgerald Lowers Price Target On LoopNet (LOOP) To $18
-
Cantor Fitzgerald Downgrades RadiSys (RSYS) to Hold
-
Cantor Fitzgerald downgrades Sonic Foundry (SOFO) to Hold
-
Cantor Fitzgerald Upgrades Sonus Networks (SONS) to Buy
-
MFA Mortgage (MFA) To Offer 20M Shares
-
Notable Analyst Rating Changes 1/07: LLY, DTV, BCR Upgraded; BBY, MOT, IBM, UNH Downgraded
-
Cantor Fitzgerald Starts Navios Maritime Partners (NMM) at Buy
-
Cantor Fitzgerald Defends Realty Income (O) On Tenant Fears
-
Cantor Fitzgerald upgrades Double Hull Tankers (DHT) to Buy
-
Shutterfly (SFLY) Slammed On Competitive Concerns; Analyst Defends
-
Advaxis to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $40 Million of Common Stock
-
Satsuma Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
